Skip to content

Risk Academy, led by the Nexus Consortium · Health and Society · Department of Global Health Security

Biosafety, biosecurity, dual-use oversight and neurotechnology governance

Ubuchwepheshe bezinto eziphilayo, ukuvikeleka kwezinto eziphilayo nobuchwepheshe bemizwa

This field studies the governance of biological research and biotechnology: how institutions prevent accidental harm, deter misuse and keep oversight proportionate.

Map biotechnology, biosecurity and neurotechnology on a real placeSee the courses

Illustrative: two backbones and their base pairs, the major and minor grooves, a reading frame travelling along the strand

01Ububanzi

What the discipline covers

The subtopics its courses and labs teach.

Izifundo
In preparation
Amazinga
In development
Amalabhorethri
Network lab
  • Laboratory biosafety and biosecurity
  • Dual-use research oversight
  • Synthetic biology governance
  • Biomanufacturing risk
  • Diagnostics and medical countermeasures
  • Agricultural biotechnology
  • Biological threat preparedness
  • Ethics and responsible research
  • Neurotechnology and neural data

Courses in development extend the scope to further subjects: Neurotechnology rights and governance; Biosecurity governance and oversight.

02Amamephu

Build a twin of any place

Search any place or open the world; the layers and generators follow biotechnology, biosecurity and neurotechnology on the planet map, the globe and in 3D.

Delhi and its National Capital Territory core: a flat plan of the faculty twin. Terrain 191 to 315 m; 950 hospitals; 26,073,018 people in the box, 2020; Population density, GPW v4.11 (2020): read live when the 3D twin opens; Air quality, Copernicus CAMS via Open-Meteo (hourly, 5 days): read live when the 3D twin opens; Nitrogen dioxide column, TROPOMI (Sentinel-5P): read live when the 3D twin opens; Surface air temperature, AIRS (daily, day): read live when the 3D twin opens; Urban heat island, summer daytime 2013: read live when the 3D twin opens; Built-up and settlement extent, HBASE 2010: read live when the 3D twin opens. Contours every 50 metres from the elevation grid; people per cell, worldpop 2020 as four classes per cell (edges 4,474, 14,627, 25,652); hospitals as marks.
Delhi and its National Capital Territory core, India. Flat plan of the same data: relief as contours from the inline grid, the WorldPop count grid as cells, the mapped hospitals and the numbers below. The 3D twin opens on devices that can draw it, once its data and code have been checked.
  • Terrain 191 to 315 m
  • 950 hospitals
  • 26,073,018 people in the box, 2020
  • Population density, GPW v4.11 (2020): read live when the 3D twin opens
  • Air quality, Copernicus CAMS via Open-Meteo (hourly, 5 days): read live when the 3D twin opens
  • Nitrogen dioxide column, TROPOMI (Sentinel-5P): read live when the 3D twin opens
  • Surface air temperature, AIRS (daily, day): read live when the 3D twin opens
  • Urban heat island, summer daytime 2013: read live when the 3D twin opens
  • Built-up and settlement extent, HBASE 2010: read live when the 3D twin opens
Credits and dates per layer are listed under the stage. Relief in the twin is exaggerated ×1.5 for legibility.

Drag to move, right drag or Shift with a drag to turn and tilt, Ctrl with the wheel to zoom. Keyboard: arrows move, Shift with arrows turn and tilt, + and – zoom, 0 resets, V steps through the views, Escape clears.

Flat plan of the same data: relief as contours from the inline grid, the WorldPop count grid as cells, the mapped hospitals and the numbers below. The 3D twin opens on devices that can draw it, once its data and code have been checked.

The boundaries, names and designations shown do not imply any judgement on the legal status of any territory, or any endorsement or acceptance of such boundaries. Countries: Natural Earth (public domain).

03The subject

The subject, methods and measures and debates and bodies

The discipline

The field and its scope

For laboratory directors, research funders, regulators and policy analysts who must govern life science research, biomanufacturing and neurotechnology proportionately to the risk.

This field studies the governance of biological research and biotechnology: how institutions prevent accidental harm, deter misuse and keep oversight proportionate. Biosafety concerns containment and the protection of workers, communities and the environment. Biosecurity concerns the security of biological materials and information, and the oversight of research whose results could be misapplied. Biotechnology governance covers synthetic biology, biomanufacturing, diagnostics, agricultural applications and, increasingly, the convergence of these fields with computational tools. The subject matter is institutional: who reviews, who screens, who reports, who decides, and on what evidence.

The field sits between microbiology, security studies, ethics, law and public administration. It is organised around the Biological Weapons Convention of 1972, which has no verification mechanism and a small implementation support unit; the WHO laboratory biosafety manual and its global guidance framework for the responsible use of the life sciences published in 2022; national frameworks for research of concern; and voluntary industry practice, including the screening of commercial gene synthesis orders. Neurotechnology enters as a governance subject through neural data, cognitive liberty and the regulation of devices, with UNESCO and the OECD setting early principles. Hazards in this chapter are named at category level only.

Measures

Quantities and units

QuantityUnit or scaleWhat to know
Containment level of a facilitybiosafety level 1 to 4A classification of facilities and practices, not a measurement of risk. The fourth edition of the WHO laboratory biosafety manual moved to a risk-based approach in which controls follow an assessment rather than the agent's label alone.
Laboratory-acquired infectionsreported incidents per year, or per 1,000 workersUnder-reported and collected without a common denominator. Published series come from voluntary surveys and literature reviews, so trends cannot be read as changes in underlying rates.
Biosafety and biosecurity capacity scorescore 1 to 5 in the Joint External EvaluationScores legal frameworks, oversight arrangements and training rather than observed practice in laboratories. Evaluations are periodic and partly self-nominated, so comparisons across countries are indicative.
Coverage of gene synthesis order screeningshare of providers and of orders screenedKnown mainly from members of the International Gene Synthesis Consortium and from self-reports. Providers outside voluntary arrangements are not represented, so the published share overstates coverage of the market.
Institutional review throughputproposals reviewed under dual-use policies per yearPublished by some funders and institutions. The count depends on the definition used in each policy, so figures are not comparable between countries and omit unfunded and private work.

Izindlela

Methods and their limits

Each method is listed with what it assumes and where it fails.

IndlelaAssumesFails when
Biosafety risk assessmentThat the hazard of an agent, the procedure, the scale of work and the competence of staff can be combined into a risk level matched to a set of controls, as in the WHO manual.When the assessment is static while the work changes, when human factors such as fatigue and production pressure are left out, and when the institution rewards throughput over the reporting of near misses.
Dual-use research oversightThat a committee with scientific and security expertise can identify, before funding or publication, work whose results could be misapplied, and can attach conditions.At the boundary between clearly benign and clearly concerning work, where most cases sit; when committees lack security expertise or time; and when equivalent knowledge is available from sources that no committee reviews.
Order and customer screening by synthesis providersThat orders can be checked against reference lists and that customers and institutions can be verified before material is shipped.Where providers sit outside voluntary arrangements, where benchtop devices remove the provider from the transaction, and where reference lists lag behind the published literature.
Horizon scanning and technology assessmentThat expert elicitation and literature monitoring can identify capabilities likely to change the risk picture within a few years, and rank them for attention.When anchored on historical programmes rather than current practice, when expert panels share a discipline and miss adjacent fields, and when the output is a list with no owner for action.
Neural data governance assessmentThat neural signals can be treated as personal data with identifiable inference risks, and that consent, purpose limitation and security controls can be applied to devices and datasets.When consumer devices sit outside medical device regulation, when inference capability advances faster than the classification, and when neural data is combined with other sources that carry their own permissions.

Debates

What the field debates

How should oversight of research with pandemic potential be organised?
One position holds that national funder policies and institutional committees, strengthened since 2024, give proportionate review close to the science and preserve the research that supports countermeasures. The other holds that review arriving after a project is designed and confined to publicly funded work leaves much of the field uncovered, and that an international mechanism with a common definition is needed. Both sides cite the absence of a verification mechanism under the Biological Weapons Convention.
Does the convergence of computational tools and biology change the risk picture enough to warrant new controls?
Some assessments argue that assistance at the design stage lowers barriers that once required tacit expertise, and they favour screening obligations at the point of material supply and evaluation requirements for capable models. Others argue that published evaluations have not shown a decisive change against an already accessible scientific literature, that physical and tacit barriers remain the binding constraint, and that broad controls would slow beneficial work without reducing the risk.
Should neurotechnology be governed as a medical device, as a data regime, or as a human rights question?
Device regulators argue that safety and efficacy frameworks already cover implanted and clinical systems and extend naturally to the rest. Data protection authorities argue that the decisive risk is inference from neural signals, which is a processing question regardless of device class. A third position, advanced through UNESCO's work on the ethics of neurotechnology, argues that mental privacy and cognitive liberty need explicit rights language because consent at the point of purchase cannot carry that weight.

Bodies and data

Bodies that set practice, and the data they publish

Bodies and standards are named so learners can find and apply their published work; the Academy teaches their use and links to the publisher, and no affiliation is implied.

BodyRole in the field
World Health OrganizationPublishes the laboratory biosafety manual and the global guidance framework for the responsible use of the life sciences, and supports national biosafety and biosecurity capacity.
Biological Weapons Convention Implementation Support UnitSupports States Parties to the Convention, administers confidence-building measure submissions and services the meetings where oversight proposals are discussed.
International Biosecurity and Biosafety Initiative for ScienceAn independent body working on common screening practice for commercial gene synthesis and on support for providers that adopt it.
Nuclear Threat Initiative bio programmePublishes analysis of biosecurity governance gaps and convenes work on international oversight mechanisms and synthesis screening.
UNESCODeveloped international standard-setting work on the ethics of neurotechnology, covering neural data, mental privacy and the governance of devices.
Organisation for Economic Co-operation and DevelopmentIssued the recommendation on responsible innovation in neurotechnology and maintains work on biotechnology policy and biological resource infrastructure.
DatasetSteward
Joint External Evaluation country reportsWorld Health Organization
Biological Weapons Convention documents and confidence-building measuresUnited Nations Office for Disarmament Affairs
Global Health Security IndexNuclear Threat Initiative and Johns Hopkins Center for Health Security

04Indlela

From an order to a review: how screening coverage and review capacity govern synthetic biology

Biosecurity governance is a pipeline with measurable stages: the share of gene synthesis orders that reach a provider who screens, the share of screened orders flagged for human review, and the number of reviews an oversight body can complete in a year; a gap at any stage is a number, and the decision is where to spend to close it.

Sources: World Health Organization, Global guidance framework for the responsible use of the life sciences (2022); National Academies of Sciences, Engineering, and Medicine, Biodefense in the age of synthetic biology (2018); National Research Council, Biotechnology research in an age of terrorism (2004); Lipsitch and Inglesby, Moratorium on research intended to create novel potential pandemic pathogens (2014).

05At a glance

At a glance, standards and evidence, research and evidence, what is changing and learning

Igrafu ye-3D

Isikhungo Sezempilo Nomphakathi

218 nodes1,500 relations9 views

Explore the 3D graph: Faculty of Health and Society

06Ikhonsoli

How Biotechnology, biosecurity and neurotechnology is taught, as a process you can run

Press Play to run this process from this page's own data.

Ubuchwepheshe bezinto eziphilayo, ukuvikeleka kwezinto eziphilayo nobuchwepheshe bemizwa

How Biotechnology, biosecurity and neurotechnology is taught

5 subjects in scope, 3 key terms, courses in development, 1 lab, in the Global Health Security department of Health and Society: from the scope to the method and its terms, the courses that teach it, the labs on the twin, the assessment and the record.

  1. 01 Scope

    1. 01

      Laboratory biosafety…

      Start · the discipline

      Laboratory biosafety and biosecurity

    2. 02

      Dual-use research…

      Start · the discipline

      Dual-use research oversight

    3. 03

      Synthetic biology…

      Start · the discipline

      Synthetic biology governance

    4. 04

      Biomanufacturing risk

      Start · the discipline

      Biomanufacturing risk

    5. 05

      Diagnostics and medical…

      Start · the discipline

      Diagnostics and medical countermeasures

  2. 02 Method and terms

    1. 06

      From an order to a…

      Model · the learner

      Biosecurity governance is a pipeline with measurable stages: the share of gene synthesis orders that reach a provider who screens, the…

    2. 07

      Biosafety

      Record · the discipline

      Practices and controls that prevent unintended exposure to or release of biological agents.

    3. 09

      Ukuphepha kwezinto eziphilayo

      Record · the discipline

      Measures that prevent the loss, theft or misuse of biological agents and knowledge.

    4. 11

      Dual-use research of…

      Record · the discipline

      Life sciences research that could be misapplied to cause harm.

  3. 04 Labs

    1. 08

      Umfanekiso wedijithali

      Exercise · the learner, on the faculty twin

      The method runs on the faculty twin and the admitted map layers.

  4. 05 Assess

    1. 10

      Module checks

      Gate · the course

      Each module ends with a short check against its outcomes.

    2. 12

      Assessed work

      Decision · the learner

      The assessed work that closes a course: a lab record, a case memo or an assignment, reviewed against the rubric.

  5. 06 Record

    1. 13

      Irekhodi lokuphothula

      Outcome · the learner

      The record stacks into the discipline achievement.

    2. 14

      Discipline achievement

      Record · the Academy

      The discipline achievement follows the discipline rule, read from the records.

Biotechnology, biosecurity and neurotechnology · Global Health Security An outline of how the work is designed to run; it does not report the status of any decision or record.

07Umkhuba

Practice, learning and connections

Technology in this area

How technology helps and what risk it brings

AspectIn this area
Technology that helpsAI-assisted diagnostics, genomic surveillance and digital health.
Risk technology createsRansomware in hospitals, AI medical device risk, biosecurity and neurotechnology.
  • RAN-316 Health Care Risk and Hospital Resilience In preparation
  • RAT-260 AI Assurance, Audit and Conformity Assessment In development
  • RAS-419 Biosecurity Governance and Oversight In development
  • RAF-129 Neurotechnology: Rights, Privacy and Governance In development

Impumelelo

Achievements in this discipline

  1. Course achievements

    One for each course with this as its primary discipline, earned when you pass the course's assessed activities.

  2. Discipline: Biotechnology, biosecurity and neurotechnology

    Complete 3 assessed courses in biotechnology, biosecurity and neurotechnology, at least 2 with it as their primary discipline and at least 1 at Intermediate (L2) or above, totalling at least 45 measured learning hours. In development.

  3. Department: Global Health Security

    Earn two discipline achievements in the Department of Global Health Security. In development.

  4. Programme: Nexus-Based Risk Management flagship pathway

    Complete every core course of the Nexus-Based Risk Management flagship pathway under assessed completion, ending with its capstone. In development.

An achievement is a record of the learning completed and assessed here. How recognition works.

Izindlela

Pathways that teach it

Where this is practised

Where the subject is practised

  • The Global Centre for Risk and Innovation (GCRI Canada)Biotechnology and BiosecurityAgricultural biotechnology, Biological threats, Biomanufacturing, Diagnostics and therapeutics, Dual use and ethics, Lab biosafety and biosecurity, One health impacts, Synthetic biology
  • The Global Risks Forum (GRF)Health and Biosecurity GovernanceBiological risk governance

Field platforms of the ecosystem where the subject is studied and applied.

Practised in

The two Foundry systems where it is practised

Foundry system pages describe what each system and its rooms are designed to do; the courses teach the methods these systems apply.

Across the ecosystem

Across the ecosystem

The science, platforms and standards this discipline draws on and contributes to across the ecosystem.

Foundations in the STEM Commons

  • The Global Centre for Risk and Innovation (GCRI Canada)Biotechnology platformsBiotechnology platforms apply biological systems to produce medicines, diagnostics, materials and agricultural products.
  • Molecular and life sciencesMolecular and life sciences study the structure and function of living systems from genes and proteins to cells and organisms.
  • Epidemiology and public health scienceEpidemiology studies the distribution and determinants of health and disease in populations.

Standards for the field

Pages of the ecosystem, cited so learners can follow the field into research, platforms, standards and national practice.

08Bamba iqhaza

Take part in Health and Society

Qala kulokho ongikho.

Izindlela

  • Indlela

    Izikhungo zikazwelonke

    Iminyango kahulumeni, amahhovisi ezibalo nama-ejensi: idesiki likazwelonke nesahluko, nesihlalo emaqenjini okusebenza. Izahluko zikazwelonke

  • Indlela

    Imikhakha nemisebenzi

    Operators, regulators, banks, insurers and professional bodies whose work touches health and society. For organisations

  • Indlela

    Ukufunda

    Izifundo nokuzijwayeza, nerekhodi lazo zonke izifundo eziqediwe. Mahhala ukufunda. Ukufunda okuvulekile

  • Indlela

    Amazinga

    Bhala okusalungiswa, buyekeza futhi wamukele izindlela namazinga edatha namaqembu okusebenza. Amaqembu okusebenza

  • Indlela

    Imiphakathi nocwaningo

    Universities, civil society and individual experts: projects, data and review. Write to the Academy

Izimemo ezivulekile

Isimemo esivulekileKufunwaKuvalwa
Isimemo sokusungula sochwepheshe emaqenjini okusebenza CALL-FOUNDING-EXPERTSuchwepheshe, umhleli, usihlalo2026-12-15
Ukuqokwa okuvulekile kwezihlalo ezintathu zochwepheshe abazimele ze-Global Standards Council CALL-GSC-INDilungu lomkhandlu2026-12-01
Ukuqokwa kwamalungu esifunda esikhashana (kusebenza kuphela uma isinqumo sesikhashana sithathwa) CALL-GSC-REGilungu lomkhandlu2026-12-15
Ukubuyekezwa kwezinhlaka zomongo wengozi wegagasi 1 (C1, C2, C3, C4, C8, C10, C11) CALL-REVIEW-WAVE1umnikeli2027-01-31
Ochwepheshe bamazinga ayisisekelo esayensi yengozi: ukungaqiniseki nokulinganiswa kobufakazi, izilinganiso, ukwahlulela kochwepheshe okuhlelekile, ukubekezeleleka, izimo ezeqisayo nezehlakalo ezihlanganisiwe, ingozi eyinhlekelele neyokuphila, izimiso nokulingana, amayunithi nokulinganisa (NRS-C17 kuya ku-NRS-C24) CALL-CORE-SCIENCEuchwepheshe, umhleli, usihlalo2027-01-31
Ababuyekezi abazimele bemindeni ye-atlas yezingozi, abathathu abavela okungenani ezifundeni ezimbili emndenini ngamunye (NHS2-R19), imindeni ehamba phambili kuqala CALL-ATLAS-REVIEWuchwepheshe2027-03-31
Amalungu e-Frontier Safety Review Panel yesikhashana nababuyekezi beqembu elibomvu (ukuphepha kwezinto eziphilayo nokuvikeleka kwazo, ukuphepha nokuvikeleka kwe-AI, ukuvikeleka kwengqalasizinda ebalulekile); izicelo ziphathwa ngokuyimfihlo CALL-FRONTIER-SAFETY-REVIEWuchwepheshe2026-11-30
Ochwepheshe be-ontology, i-metrology, ukuqinisekiswa kwesofthiwe nokuhlolwa kokuhambisana kwerejista yezidingo, ukumelwa komshini kwe-NHS-2, amasethi okuhlola ukuhambisana nohlelo lokuhlola ukuhambisana CALL-CONFORMANCE-ONTOLOGYuchwepheshe, umhleli2027-01-31

Izimemo ezidlule usuku lwazo lokuvala zifihlwa ngokuzenzakalelayo. Zonke izimemo, iziphakamiso nezindlela: izindawo nezimemo ezivulekile.

Amaseli nama-CERT

  1. Qoqa iseli

    Hlanganisa abantu abathathu kuya kwabayisikhombisa abanamakhono ahambisanayo: idatha, ukusebenza enkundleni, inqubomgomo nokuxhumana.

  2. Libhalise

    Write to the team with the cell's name, members, area and region. You receive a reference and a contact. Write to the Academy

  3. Khetha umqulu

    Khetha ukugxila okukodwa: ucwaningo nobufakazi, idatha namamephu, ukubuyekezwa kwamazinga, noma ukulungiselela komphakathi.

  4. Funda ndawonye

    Landela izindlela zokufunda ezabelwana ngazo e-Risk Academy, nokuzijwayeza nerekhodi lazo zonke izifundo eziqediwe. Izinsongo nokuqina

  5. Hola futhi ubike

    Hold regular sessions. Publish what the cell learns through Reports. Bring findings to the working groups. Working groups

  • Gxila njengeThimba Lomphakathi Lokusabela Ezimweni Eziphuthumayo (CERT)

    A CERT prepares its neighbourhood for the hazards it faces. It builds a local hazard profile from this site's map. It trains in household and street preparedness. It learns first aid and light search through recognised local providers, and it runs drills. A CERT works alongside the local emergency services and follows their direction. It never replaces them and is not an emergency service.

I-Index

What a national team or a local community can do on The Global Risks Index (NXS-GRX) today.

  • NXS-GRX

    Your country's profile

    Amaphrofayela engozi avulekile amazwe angu-195, nemithombo namalayisense kuyo yonke inani. Vula Inkomba

  • NXS-GRX

    Lungisa noma uphendule

    Lungisa inani noma uphendule ngezwe lakho. Ushintsho lurekhodwa kanye nomphumela walo. Vula Inkomba

  • NXS-GRX

    Nikela ngedatha

    Nikela ngeqoqo ledatha. Lingena ngesango lelayisense, ubongwa. Vula Inkomba

  • NXS-GRX

    Sebenzisa idatha evulekile

    Izendlalelo, amaphrofayela namathayela nge-API evulekile. Vula Inkomba

09References

Core references and where to begin

Start with World Health Organization, then World Health Organization, then National Research Council.

  1. World Health Organization, Laboratory biosafety manual, fourth edition (2020). who.int
  2. World Health Organization, Global guidance framework for the responsible use of the life sciences (2022). who.int
  3. National Research Council, Biotechnology research in an age of terrorism (2004). DOI
  4. Lipsitch and Inglesby, Moratorium on research intended to create novel potential pandemic pathogens (2014). DOI
  5. National Academies of Sciences, Engineering, and Medicine, Biodefense in the age of synthetic biology (2018). DOI
  6. Fauci, Research on highly pathogenic H5N1 influenza virus: the way forward (2012). DOI
  7. Yuste and others, Four ethical priorities for neurotechnologies and AI (2017). DOI
  8. Ienca and Andorno, Towards new human rights in the age of neuroscience and neurotechnology (2017). DOI

10Imibuzo

Imibuzo, izimpendulo namagama abalulekile

Ukufunda lapha kungamahhala yini?

Yebo. Zonke izinkambo nezinto zokufunda ze-Risk Academy, eholwa yi-Nexus Consortium, zifundwa mahhala, ngesivinini sakho noma neqembu. Ukubamba iqhaza okujwayelekile akunayo inkokhelo; umsebenzi ohlawulelwayo, ukuqeqeshwa emsebenzini nezibonelelo zocwaningo kuyizinhlelo ezihlukile.

Kuyini engikuthola ngokuphothula isifundo?

Irekhodi lokuphothula: isifundo, inguqulo yaso, usuku nokuhlolwe, eliyimfihlo ngokuzenzakalelayo futhi labelwana nguwe. Lihlangana libe yimiphumela yomkhakha, yomnyango neyohlelo. Irekhodi likhomba okufundiwe nokuhlolwe, alisho ukuthi ukhono luqinisekisiwe; akulona ilayisense, isihloko sobuchwepheshe noma isimo somsebenzi.

Idatha nezindawo zivelaphi?

Ifakhalthi ngayinye ifundisa ngamawele endawo yangempela akhiwe ngedatha evulekile; isendlalelo ngasinye siveza umhlinzeki waso, ilayisense nosuku, futhi umphumela ngamunye ku-Academy uveza umthombo wawo. Amamephu nezibalo yizinkombandlela zokufundisa, ayisona isilinganiso sendawo.

How do I take part beyond the courses in biotechnology, biosecurity and neurotechnology?

Yakha iseli lekhono labantu abathathu kuya kwabayisikhombisa, funda indlela okwabelwana ngayo, thatha umsebenzi ogadiwe kuma-National Working Groups, noma ulethe iqembu labafundi elivela esikhungweni sakho. Ezinhlanganweni.

Amagama abalulekile

Biosafety
Practices and controls that prevent unintended exposure to or release of biological agents.
Ukuphepha kwezinto eziphilayo
Measures that prevent the loss, theft or misuse of biological agents and knowledge.
Dual-use research of concern
Life sciences research that could be misapplied to cause harm.
Medical countermeasure
A vaccine, therapeutic or diagnostic used against a health threat.

ImibikoNikela

Nikela ngobufakazi kusuka kuleli khasi.

I-Reports iyincwadi yekota ye-Consortium. Lokho oakwaziyo ngalesi sihloko kungaba ubufakazi, icala noma ukulungisa kuhlelo olulandelayo, kubongwe wena futhi kushicilelwe ngaphansi kwe-CC BY 4.0 lapho kungumsebenzi wakho.

Risk Academy

Ungalokothi uthumele idatha yomuntu siqu, imininingwane ebucayi yengqalasizinda noma noma yini ongenalo ilungelo lokuyabelana ngayo. Umnikelo ubuyekezwa ngaphambi kokusetshenziswa; ukuwuthumela akunikezi ubuqambi noma amalungelo okuhlela, futhi ukusekela akuthengi muphumela.

Ubuchwepheshe bezinto eziphilayo, ukuvikeleka kwezinto eziphilayo nobuchwepheshe bemizwa

Prepare with a related course

Open courses in connected disciplines teach the methods this discipline will build on.

Buka ikhathalogi yezifundoBack to Department of Global Health Security